Life Sciences Times, Author at Boston Life Sciences Times

Study Links Tumor Metabolism to Drug Binding Behavior in Live Cancer Cells

December 9, 2025

Entrepreneur of the Year Award Honors Dermatology Innovator Reid Waldman, M.D.

December 8, 2025

Thermo Fisher Scientific Expands Bioprocess Design Centers to Strengthen Asia’s Biopharma Ecosystem

December 3, 2025

THIS WEEK'S STORIES

InduPro Therapeutics announces strategic investment and research collaboration with Sanofi to advance bispecific candidate for autoimmune disorders

December 10, 2025

BostonGene to Present Seven AI-Driven Breast Cancer Studies at SABCS 2025

December 8, 2025

Aleta Biotherapeutics and Cancer Research UK Report Early Phase I/II Results for ALETA-001 in B-Cell Malignancies

December 9, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

Barking, Havering and Redbridge University Hospitals NHS Trust adopts Wolters Kluwer’s UpToDate Enterprise Edition to strengthen clinical decision-making

Vektor Medical receives FDA 510(k) clearance expanding vMap’s non-invasive cardiac mapping capabilities

Allonnia raises more than $20 million to accelerate deployment of materials biotechnology

InduPro Therapeutics announces strategic investment and research collaboration with Sanofi to advance bispecific candidate for autoimmune disorders

EDITOR PICKS

Study Links Tumor Metabolism to Drug Binding Behavior in Live Cancer Cells

Entrepreneur of the Year Award Honors Dermatology Innovator Reid Waldman, M.D.

Thermo Fisher Scientific Expands Bioprocess Design Centers to Strengthen Asia’s Biopharma Ecosystem

THIS WEEK'S STORIES

InduPro Therapeutics announces strategic investment and research collaboration with Sanofi to advance bispecific candidate for autoimmune disorders

BostonGene to Present Seven AI-Driven Breast Cancer Studies at SABCS 2025

Aleta Biotherapeutics and Cancer Research UK Report Early Phase I/II Results for ALETA-001 in B-Cell Malignancies

POPULAR CATEGORY

ABOUT US

FOLLOW US